Exploring the utility of the Threshold of Toxicological Concern (TTC) as a screening approach for complex substances.

Chemical mixtures Combined exposures Complex substances Human health risk assessment Multiple chemicals Screening of toxic chemicals Threshold of toxicological concern

Journal

Regulatory toxicology and pharmacology : RTP
ISSN: 1096-0295
Titre abrégé: Regul Toxicol Pharmacol
Pays: Netherlands
ID NLM: 8214983

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 30 06 2021
revised: 10 09 2021
accepted: 29 09 2021
pubmed: 7 10 2021
medline: 20 1 2022
entrez: 6 10 2021
Statut: ppublish

Résumé

The Threshold of Toxicological Concern (TTC) has been applied to assess chemical safety for use, particularly in the food safety area. Although the TTC was developed for application to an individual chemical structure, more recently this concept has been suggested for the assessment of combined exposures to multiple chemicals. This study evaluated the potential for applying the TTC to a specific type of co-exposure, that of a complex substance of variable composition which contains multiple constituents, following the World Health Organization/International Programme on Chemical Safety framework for risk assessment of combined exposure to multiple chemicals. The results indicated that the TTC threshold was lower (i.e., more conservative) than regulatory thresholds derived for the same substance or even its most toxic constituent, providing assurance that the TTC could meet the requirements for a conservative screening process. This case study indicates that the TTC concept can be a useful tool to screen for potential risks from complex substances, with the consideration of additional aspects such as variability in chemical constituents and their relative proportions within the substance.

Identifiants

pubmed: 34614434
pii: S0273-2300(21)00192-6
doi: 10.1016/j.yrtph.2021.105051
pii:
doi:

Substances chimiques

Complex Mixtures 0
Hexanes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105051

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

R Zaleski (R)

ExxonMobil Biomedical Sciences Inc, 1545 Route 22 East, Annandale, NJ, 08801, USA. Electronic address: rzaleski10@gmail.com.

M Embry (M)

Health and Environmental Sciences Institute, 740 15th Street NW, Suite 600, Washington, DC, 20005, USA. Electronic address: membry@hesiglobal.org.

R McKee (R)

ExxonMobil Biomedical Sciences Inc, 1545 Route 22 East, Annandale, NJ, 08801, USA; Hillsborough, NJ, USA. Electronic address: richardmckee3@gmail.com.

L K Teuschler (LK)

LK Teuschler & Associates, 6634 Tenth Avenue Terr So, St. Petersburg, FL, 33707, USA. Electronic address: lindateuschler@gmail.com.

Articles similaires

Humans Neoplasms Male Female Middle Aged
Humans Patient Reported Outcome Measures Neoplasms Electronic Health Records Delivery of Health Care
Humans Retrospective Studies Male Critical Illness Female

Classifications MeSH